HBV serological markers of vaccinated children in remote areas of Taiwan: Emphasis on factors contributing to vaccine failure

Vaccine

Volumn 25, Issue 34, 2007, Pages 6326-6333

  Huang, Mei Liang ^a,b   Liao, Wen Ling ^a,b   Ho, Mei Shang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

HBV; Vaccine efficacy; Vaccine escape variant

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; DISEASE SURVEILLANCE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SEROCONVERSION; SEROEPIDEMIOLOGY; TAIWAN; VACCINE FAILURE;

CARRIER STATE; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MULTIVARIATE ANALYSIS; MUTATION; PREVALENCE; TAIWAN; VACCINATION;

EID: 34447648002     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.022     Document Type: Article

References (37)

1. Yoffe B., and Noonan C.A. Progress and perspectives in human hepatitis B virus research. Progress in Medical Virology Fortschritte der Medizinischen Virusforschung 40 (1993) 107-140
2. Stevens C.E., Beasley R.P., Tsui J., and Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292 April (15) (1975) 771-774
3. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2 November (8256) (1981) 1129-1133
4. Chiou S.S., Obata H., Takasaki T., Fukushima Y., Motoike Y., Okuda H., et al. Hepatitis viruses in southern Taiwan-mass survey of 2985 inhabitants. Gastroenterologia Japonica 19 August (4) (1984) 344-350
5. Tsen Y.J., Chang M.H., Hsu H.Y., Lee C.Y., Sung J.L., and Chen D.S. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 34 June (2) (1991) 96-99
6. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 276 September (11) (1996) 906-908
7. Lin D.B., Wang H.M., Lee Y.L., Ling U.P., Changlai S.P., and Chen C.J. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. Vaccine 16 October (17) (1998) 1683-1687
8. Ni Y.H., Chang M.H., Huang L.M., Chen H.L., Hsu H.Y., Chiu T.Y., et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135 November (9) (2001) 796-800
9. Lu S.N., Chen C.H., Chen T.M., Lee P.L., Wang J.H., Tung H.D., et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 24 February (6) (2006) 759-765
10. Chung D.C., Ko Y.C., Chen C.J., Wu C.C., Chen E.R., Liaw Y.F., et al. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol 26 December (4) (1988) 411-418
11. Hsu L.C., Lin S.R., Hsu H.M., Chao W.H., Hsieh J.T., Wang M.C., et al. Ethnic differences in immune responses to hepatitis B vaccine. Am J Epidemiol 143 April (7) (1996) 718-724
12. Wu Y.F., Wang L.Y., Lee T.D., Lin H.H., Hu C.T., Cheng M.L., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 72 January (1) (2004) 17-25
13. Wang L.Y., Hu C.T., Ho T.Y., and Lin H.H. Geographic and ethnic variations of long-term efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine 24 May (20) (2006) 4427-4432
14. Trivello R., Chiaramonte M., Ngatchu T., Baldo V., Majori S., Moschen M.E., et al. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine 13 February (2) (1995) 139-141
15. Lindh M., Andersson A.S., and Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175 June (6) (1997) 1285-1293
16. Ho M., Mau Y., Lu C., Huang S., Hsu L., Lin S., et al. Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. A population-based comparative study. J Biomed Sci 5 September-October (5) (1998) 355-362
17. Okamoto H., Imai M., Tsuda F., Tanaka T., Miyakawa Y., and Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61 October (10) (1987) 3030-3034
18. Norder H., Hammas B., Lofdahl S., Courouce A.M., and Magnius L.O. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol 73 May (Pt 5) (1992) 1201-1208
19. Ko Y.C., Liu B.H., and Hsieh S.F. Issues on aboriginal health in Taiwan. Kaohsiung J Med Sci 10 July (7) (1994) 337-351
20. Chotard J., Inskip H.M., Hall A.J., Loik F., Mendy M., Whittle H., et al. The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis 166 October (4) (1992) 764-768
21. Delage G., Remy-Prince S., and Montplaisir S. Combined active-passive immunization against the hepatitis B virus: five-year follow-up of children born to hepatitis B surface antigen-positive mothers. Pediatr Infect Dis J 12 February (2) (1993) 126-130
22. Milne A., Hopkirk N., and Moyes C.D. Hepatitis B vaccination in children: persistence of immunity at 9 years. J Med Virol 44 October (2) (1994) 113-114
23. West D.J., Watson B., Lichtman J., Hesley T.M., and Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J 13 August (8) (1994) 745-747
24. Lin Y.C., Chang M.H., Ni Y.H., Hsu H.Y., and Chen D.S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 187 January (1) (2003) 134-138
25. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 August (11) (1996) 1019-1027
26. Stevens C.E., Toy P.T., Taylor P.E., Lee T., and Yip H.Y. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 90 July (1 Pt 2) (1992) 170-173
27. Chan C.Y., Lee S.D., Tsai Y.T., Yue M.I., and Lo K.J. Long-term follow-up of hepatitis B vaccination in infants born to noncarrier mothers in Taiwan. Chin Med J 50 August (2) (1992) 83-88
28. Anonymous. Recommendations of the immunization practices advisory committee update on hepatitis B prevention. MMWR 36 June (23) (1987) 353-366
29. Migneco G., Valentino L., Tripi S., Portera M., La Cascia C., Dardanoni G., et al. HBV infection risk in hospital workers. Bollettino dell'Istituto sieroterapico milanese 66 1 (1987) 18-22
30. Martinson F.E., Weigle K.A., Royce R.A., Weber D.J., Suchindran C.M., and Lemon S.M. Risk factors for horizontal transmission of hepatitis B virus in a rural area in Ghana. Am J Epidemiol 147 March (5) (1998) 478-487
31. Farza H., Salmon A.M., Hadchouel M., Moreau J.L., Babinet C., and Tiollais P. Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice. Proc Natl Acad Sci USA 84 March (5) (1987) 1187-1191
32. Chang M.H. Hepatitis B virus infection. Semin Fetal Neonatal Med 27 (2007)
33. Burk R.D., Hwang L.Y., Ho G.Y., Shafritz D.A., and Beasley R.P. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 170 December (6) (1994) 1418-1423
34. Milne A., West D.J., Chinh D.V., Moyes C.D., and Poerschke G. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 67 July (3) (2002) 327-333
35. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 132 April (4) (2007) 1287-1293
36. Hsu H.Y., Chang M.H., Ni Y.H., and Chen H.L. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53 October (10) (2004) 1499-1503
37. Huang M.L., Pan L.Y., Yang W.H., Hu C.M., Lin C.Y., Fann D.B.C., et al. Negative association between HLA-A2 and a low antibody response to hepatitis b vaccine in bunun ethnic children. J Genet Mol Biol 12 September (3) (2001) 151-160